© 1995 by European Society of Cardiology
Copyright © 1995, European Society of Cardiology
Intracellular signalling through protein kinases in the heart
Department of Cardiac Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK
* Corresponding author. Tel. (+44-71) 352-8121, ext. 3306; Fax (+44-71) 823-3392.
Protein kinases play important roles in intracellular signalling pathways in probably all cells. In the heart, they are involved in the regulation of ion handling, contractility, fuel metabolism and growth. In this review, we discuss the consequences of activation of protein kinases known to be expressed in the heart. We concentrate principally on the following: cyclic AMP-dependent protein kinase, protein kinase C, mitogen-activated protein kinase, Ca2+/calmodulin-dependent protein kinases and pyruvate dehydrogenase kinase.
KEYWORDS AP-1 activator protein-1; βARK β-adrenergic receptor kinase; CaM kinase Ca2+/calmodulin-dependent protein kinase; CaM calmodulin; CDK cyclin-dependent kinase; CoA coenzyme A; CREB-P cyclic AMP-responsive element binding protein; ET endothelin; G-protein GTP-binding protein; GRK G-protein-coupled receptor kinase; IP3 inositol 1,4,5-triphosphate; IRS-1 insulin receptor substrate-1; MAPK mitogen-activated protein kinase (or ERK for extracellular signal regulated kinase); MAPKAP-K1 MAPK activated protein kinase-1; MAPKK mitogen-activated protein kinase kinase (or MEK for MAPK (or ERK) kinase); MARCKS myristoylated alaninerich C kinase substrate; MEKK MEK kinase or MAPKK kinase; MLC myosin light chain; MLCK MLC kinase; NHE Na+/H+ exchanger; PDH pyruvate dehydrogenase; PDHC PDH multienzyme complex; PHAS-I phosphorylated heat- acid-stable protein regulated by insulin; pH intracellular pH; PIP2 phosphatidylinositol-4,5-bisphosphate; PIP3 phosphatidylinositol-3,4,5-triphosphate; PKC protein kinase C; PKA cyclic AMP-dependent protein kinase; PKG cyclic GMP-dependent protein kinase; PLC phospholipase C; PLD phospholipase D; PMA phorbol 12-myristate 13-acetate (or TPA for 12-O-tetradecanoyl phorbol 13-acetate); PtdSer phosphatidylserine; RACK receptor for activated C kinase; RSK ribosomal subunit S6 kinase; SR sarcoplasmic reticulum; SERCA sarcoplasmic reticulum Ca2+-dependent ATPase; Tn troponin; TRE TPA-responsive element
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Almela, N. M. Atucha, M. V. Milanes, and M. L. Laorden Cross-Talk between Protein Kinase A and Mitogen-Activated Protein Kinases Signalling in the Adaptive Changes Observed during Morphine Withdrawal in the Heart J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 771 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Yu, C.-K. Chang, H.-Y. Ou, K.-C. Cheng, and J.-T. Cheng Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats Cardiovasc Res, October 1, 2008; 80(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Deschamps, J. Zavadzkas, R. L. Murphy, C. N. Koval, J. E. McLean, L. Jeffords, S. M. Saunders, N. J. Sheats, R. E. Stroud, and F. G. Spinale Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H875 - H883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gujic, C. Dreyfuss, J.-F. Argacha, S. Beloka, D. Adamopoulos, O. Xhaet, A. Pathak, and P. van de Borne Effects of enoximone on peripheral and central chemoreflex responses in humans Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H322 - H329. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Zaloga, K. A. Harvey, W. Stillwell, and R. Siddiqui Trans Fatty Acids and Coronary Heart Disease Nutr Clin Pract, October 1, 2006; 21(5): 505 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol Cardiovasc Res, June 1, 2003; 58(3): 565 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Shin, J. V. Barnett, P. Chang, S. Reddy, D. C. Drinkwater, R. N. Pierson, R. G. Wiley, and K. T. Murray Molecular heterogeneity of protein kinase C expression in human ventricle Cardiovasc Res, November 1, 2000; 48(2): 285 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bogoyevitch Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system Cardiovasc Res, March 1, 2000; 45(4): 826 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jalili, Y. Takeishi, and R. A Walsh Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC {beta}I, and PKC Cardiovasc Res, October 1, 1999; 44(1): 5 - 9. [Full Text] [PDF] |
||||
![]() |
B. Z. Simkhovich, K. Przyklenk, and R. A. Kloner Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review Cardiovasc Res, October 1, 1998; 40(1): 9 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T Rapundalo Cardiac protein phosphorylation: functional and pathophysiological correlates Cardiovasc Res, June 1, 1998; 38(3): 559 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Simonis, R. Marquetant, J. Rothele, and R. H Strasser The cardiac adrenergic system in ischaemia: differential role of acidosis and energy depletion Cardiovasc Res, June 1, 1998; 38(3): 646 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Bilsen Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system Cardiovasc Res, December 1, 1997; 36(3): 310 - 322. [Full Text] [PDF] |
||||
![]() |
R. W. Brownsey, A. N. Boone, and M. F. Allard Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms Cardiovasc Res, April 1, 1997; 34(1): 3 - 24. [Full Text] [PDF] |
||||



